370 related articles for article (PubMed ID: 9811471)
1. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.
Rao S; Lowe M; Herliczek TW; Keyomarsi K
Oncogene; 1998 Nov; 17(18):2393-402. PubMed ID: 9811471
[TBL] [Abstract][Full Text] [Related]
2. Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells.
Carlson BA; Dubay MM; Sausville EA; Brizuela L; Worland PJ
Cancer Res; 1996 Jul; 56(13):2973-8. PubMed ID: 8674031
[TBL] [Abstract][Full Text] [Related]
3. Formation of p27-CDK complexes during the human mitotic cell cycle.
Soos TJ; Kiyokawa H; Yan JS; Rubin MS; Giordano A; DeBlasio A; Bottega S; Wong B; Mendelsohn J; Koff A
Cell Growth Differ; 1996 Feb; 7(2):135-46. PubMed ID: 8822197
[TBL] [Abstract][Full Text] [Related]
4. Adhesion-dependent control of cyclin E/cdk2 activity and cell cycle progression in normal cells but not in Ha-ras transformed NRK cells.
Carstens CP; Krämer A; Fahl WE
Exp Cell Res; 1996 Nov; 229(1):86-92. PubMed ID: 8940252
[TBL] [Abstract][Full Text] [Related]
5. Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc.
Vlach J; Hennecke S; Alevizopoulos K; Conti D; Amati B
EMBO J; 1996 Dec; 15(23):6595-604. PubMed ID: 8978686
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of cyclin-dependent kinase inactivation by progestins.
Musgrove EA; Swarbrick A; Lee CS; Cornish AL; Sutherland RL
Mol Cell Biol; 1998 Apr; 18(4):1812-25. PubMed ID: 9528753
[TBL] [Abstract][Full Text] [Related]
7. Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function.
Foster JS; Henley DC; Bukovsky A; Seth P; Wimalasena J
Mol Cell Biol; 2001 Feb; 21(3):794-810. PubMed ID: 11154267
[TBL] [Abstract][Full Text] [Related]
8. Role of cyclin A and p27 in anti-IgM induced G1 growth arrest of murine B-cell lymphomas.
Ezhevsky SA; Toyoshima H; Hunter T; Scott DW
Mol Biol Cell; 1996 Apr; 7(4):553-64. PubMed ID: 8730099
[TBL] [Abstract][Full Text] [Related]
9. Characterization of p21Cip1/Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction.
Chen IT; Akamatsu M; Smith ML; Lung FD; Duba D; Roller PP; Fornace AJ; O'Connor PM
Oncogene; 1996 Feb; 12(3):595-607. PubMed ID: 8637717
[TBL] [Abstract][Full Text] [Related]
10. Induction of p21(WAF1/CIP1) and inhibition of Cdk2 mediated by the tumor suppressor p16(INK4a).
Mitra J; Dai CY; Somasundaram K; El-Deiry WS; Satyamoorthy K; Herlyn M; Enders GH
Mol Cell Biol; 1999 May; 19(5):3916-28. PubMed ID: 10207115
[TBL] [Abstract][Full Text] [Related]
11. Role for c-Abl tyrosine kinase in growth arrest response to DNA damage.
Yuan ZM; Huang Y; Whang Y; Sawyers C; Weichselbaum R; Kharbanda S; Kufe D
Nature; 1996 Jul; 382(6588):272-4. PubMed ID: 8717045
[TBL] [Abstract][Full Text] [Related]
12. The cdk2 binding domain of p27Kip correlates with the inhibition of the kinase activity of cdk2/cyclin complexes.
Kwon TK; Buchholz MA; Nordin AA
Biochem Biophys Res Commun; 1996 Mar; 220(3):703-9. PubMed ID: 8607829
[TBL] [Abstract][Full Text] [Related]
13. ErbB2 potentiates breast tumor proliferation through modulation of p27(Kip1)-Cdk2 complex formation: receptor overexpression does not determine growth dependency.
Lane HA; Beuvink I; Motoyama AB; Daly JM; Neve RM; Hynes NE
Mol Cell Biol; 2000 May; 20(9):3210-23. PubMed ID: 10757805
[TBL] [Abstract][Full Text] [Related]
14. Differential modulation of cyclin-dependent kinase inhibitor p27Kip1 by negative signaling via the antigen receptor of B cells and positive signaling via CD40.
Han H; Nomura T; Honjo T; Tsubata T
Eur J Immunol; 1996 Oct; 26(10):2425-32. PubMed ID: 8898956
[TBL] [Abstract][Full Text] [Related]
15. Cyclin E/Cdk2 activity is controlled by different mechanisms in the G0 and G1 phases of the cell cycle.
Bresnahan WA; Boldogh I; Ma T; Albrecht T; Thompson EA
Cell Growth Differ; 1996 Oct; 7(10):1283-90. PubMed ID: 8891332
[TBL] [Abstract][Full Text] [Related]
16. p53-independent increase in p21WAF1 and reciprocal down-regulation of cyclin A and proliferating cell nuclear antigen in bromodeoxyuridine-mediated growth arrest of human melanoma cells.
Strasberg Rieber M; Welch DR; Miele ME; Rieber M
Cell Growth Differ; 1996 Feb; 7(2):197-202. PubMed ID: 8822203
[TBL] [Abstract][Full Text] [Related]
17. Neu differentiation factor (Heregulin) activates a p53-dependent pathway in cancer cells.
Bacus SS; Yarden Y; Oren M; Chin DM; Lyass L; Zelnick CR; Kazarov A; Toyofuku W; Gray-Bablin J; Beerli RR; Hynes NE; Nikiforov M; Haffner R; Gudkov A; Keyomarsi K
Oncogene; 1996 Jun; 12(12):2535-47. PubMed ID: 8700512
[TBL] [Abstract][Full Text] [Related]
18. Genetic status and expression of the cyclin-dependent kinase inhibitors in human gastric carcinoma cell lines.
Akama Y; Yasui W; Kuniyasu H; Yokozaki H; Akagi M; Tahara H; Ishikawa T; Tahara E
Jpn J Cancer Res; 1996 Aug; 87(8):824-30. PubMed ID: 8797888
[TBL] [Abstract][Full Text] [Related]
19. Activation of the endogenous p53 growth inhibitory pathway in HeLa cervical carcinoma cells by expression of the bovine papillomavirus E2 gene.
Hwang ES; Naeger LK; DiMaio D
Oncogene; 1996 Feb; 12(4):795-803. PubMed ID: 8632901
[TBL] [Abstract][Full Text] [Related]
20. Cell cycle protein suppression and p21 induction in differentiating Caco-2 cells.
Evers BM; Ko TC; Li J; Thompson EA
Am J Physiol; 1996 Oct; 271(4 Pt 1):G722-7. PubMed ID: 8897894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
